Medicaid does not pay for CBD oil purchased over the counter. CBD oils, tinctures, and other hemp-derived products sold in stores or online are classified as dietary supplements, not prescription medications, and fall outside Medicaid’s drug coverage. There is, however, one important exception: a prescription CBD medication called Epidiolex, which Medicaid can cover for specific seizure disorders.
Why CBD Oil Is Not Covered
Medicaid covers prescription drugs that have been approved by the FDA and are dispensed through a pharmacy with a valid prescription. The CBD oil products you find at health food stores, dispensaries, or online retailers don’t meet either requirement. They are marketed as supplements or wellness products, and the FDA has not approved any of them for treating medical conditions.
Even for over-the-counter products that Medicaid does sometimes cover (like certain allergy medications or pain relievers), beneficiaries typically need a prescription from a doctor. But that rule only applies to OTC products that have an FDA-approved drug status. CBD oil sold as a supplement has no such status, so getting a prescription for it won’t change anything. Medicaid simply has no mechanism to reimburse for it.
The One CBD Product Medicaid Can Cover
The FDA has approved exactly one cannabis-derived drug: Epidiolex, which contains a purified form of cannabidiol. It is a prescription medication used to treat seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients two years of age and older. Because it has full FDA approval and a national drug code, state Medicaid programs can include it on their formularies.
Coverage comes with strict requirements. Using the District of Columbia’s Medicaid criteria as a representative example, a patient must have a confirmed diagnosis from a neurologist or epileptologist, must have tried and failed at least two other seizure medications, and must use Epidiolex alongside at least one other anti-seizure drug. The prescriber also needs to verify liver function through blood tests before and during treatment, and the patient must attest they are not using recreational or medical cannabis at the same time.
These prior authorization requirements vary somewhat by state, but the general pattern is consistent: Epidiolex is reserved for patients with severe, treatment-resistant epilepsy, not for general pain, anxiety, or other conditions people commonly associate with CBD. If you or your child qualifies, the manufacturer reports that 9 out of 10 patients pay $0 in out-of-pocket costs regardless of insurance type, thanks in part to the JazzCares copay assistance program.
Medical Marijuana Programs Are Separate From Medicaid
If your state has a medical marijuana program that includes CBD products, that program operates completely independently from Medicaid. Medical marijuana is still a Schedule I substance under federal law, and since Medicaid is a joint federal-state program, it cannot reimburse for products the federal government classifies as controlled substances without FDA approval.
A few states have created their own assistance programs to help low-income patients afford medical marijuana, but these are funded through state-specific channels, not through Medicaid itself. Pennsylvania offers a good example. Its Medical Marijuana Assistance Program (MMAP) waives the annual patient card fee for people enrolled in Medicaid, SNAP, WIC, CHIP, or PACE/PACENET. For patients enrolled in the PACE or PACENET programs specifically, the state distributes a $50 monthly benefit toward medical marijuana purchases. But this money comes from a dedicated Medical Marijuana Program Fund created by state legislation, not from Medicaid dollars.
Other Ways to Reduce CBD Costs
If you’re on Medicaid and looking for CBD oil to manage a health condition, the reality is that you’ll likely be paying out of pocket. Prices for quality CBD oil range widely, from about $30 to over $150 per bottle depending on concentration and brand. A few strategies can help bring costs down.
For patients with epilepsy who may qualify for Epidiolex, pharmaceutical patient assistance programs are the most direct path. The Epilepsy Foundation maintains a directory of assistance programs from major drug manufacturers, many of which provide medication free of charge or at significantly reduced cost. Resources like NeedyMeds.org, the Medicine Assistance Tool, and RxAssist can help you search for programs you may be eligible for based on income and diagnosis.
For general CBD oil purchases, some manufacturers offer their own discount programs for low-income buyers, veterans, or people with disabilities. These vary by company and aren’t standardized, so you’ll need to check individual brand websites. Buying higher-concentration products and using smaller doses per serving can also reduce the per-day cost compared to buying low-concentration options more frequently.
What This Means for You
The short answer is clear: if you’re hoping Medicaid will reimburse you for a bottle of CBD oil from a store or dispensary, it won’t. The only CBD product Medicaid can cover is a specific prescription seizure medication, and qualifying for it requires a serious epilepsy diagnosis and documented treatment failures with other drugs. For everything else, CBD remains an out-of-pocket expense, regardless of whether your state has legalized hemp, CBD, or medical marijuana. The 2018 Farm Bill made hemp-derived CBD legal to sell in most states, but legality and insurance coverage are two very different things.